LITHOSTAT

LOE Approaching

acetohydroxamic acid

Mission Therapeutics
NDAORALTABLETPriority Review
Approved
May 1983
Lifecycle
LOE Approaching
Competitive Pressure
30/100

Mechanism of Action

Urease Inhibitors

Pharmacologic Class:

Urease Inhibitor

Company
Mission Therapeutics
Mission Therapeutics
UK - Cambridge
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers